NCT06929026Active, not recruiting
Retinal Biomarkers in Parkinson´s Disease
Retinal Biomarkers in Parkinson´s Disease: Retinal Oximetry, Pattern Electroretinography (PERG), Visual Evoked Potentials (VEP) and Optical Coherence Tomography (OCT)
Source: ClinicalTrials.gov · Last updated 15 Apr 2025
Brief summary (registry, in English)
The goal of this observational study is to determine whether oxygen content of the retinal vessels of the eye may serve as a biomarker in Parkinson´s disease. The main questions it aims to answer are: 1. Is retinal vessel oxyhemoglobin saturation and vessel width altered in people with Parkinson´s disease? 2. Is the thickness of the retinal nerve fiber layer altered in people with Parkinson´s disease? 3. Is the response of ganglion cells of the inner retina and the visual cortex altered in people with Parkinson´s disease? The study procedure is threefold. The participants will: A. Sit in front of a screen and focus on a red dot of its middle. A simple recording electrodes are applied on the cornea, forehead and scalp for the electrophysiological measurements. Prior to this procedure a topical anesthetic gel is applied to numb the eye to prevent discomfort from placement of the corneal electrodes. B. Undergo general eye examination and optical coherence tomography (OCT) to measure the retinal tissue thickness. Prior to eye examination,eye drops are applied into the eyes to enlarge the pupils C. Sit in front of a fundus camera for obtaining images of the retinal vessels to measure oxygen saturation and the vessel width Researchers will compare the obtained measurements with age- and gender matching of healthy controls.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 60 (estimated)
- First submitted
- 31 Mar 2025
- Start date
- 10 Mar 2023
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Landspitali University Hospital
- Diseases
- Parkinson disease
- NCT number
- NCT06929026
What you commit to
- Study type: Observational
- Planned participants: 60
- From 10 Mar 2023 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Eye disease
- Chronic Obstructive Pulmonary Disease (COPD)
- Other Neurological Disease
Other
- Diabetic Mellitus
- Smoking on a daily basis
Who the study is looking for
- Confirmed Parkinson Disease
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ophthalmic Outpatient Department Landspitali UH Coordinator of this site? Confirm its status | Reykjavik | Iceland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.